Improved governance and pre-release safety evaluations needed for biological AI models Post author: Post published:August 23, 2024 Post category:uncategorized Concerns over the biosecurity risks posed by artificial intelligence (AI) models in biology continue to grow. You Might Also Like Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024 June 22, 2024 Long-term acute care hospital closures may have unintended consequences for patient care November 21, 2023 Biofeedback improves speech in children at a faster rate than traditional methods September 9, 2025
Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024 June 22, 2024
Long-term acute care hospital closures may have unintended consequences for patient care November 21, 2023